Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 8, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	231,746	192,990	114,719	77,801	93,615	82,147
Market Cap Growth	24.57%	68.23%	47.45%	-16.89%	13.96%	64.00%
Enterprise Value	259,010	221,970	121,268	80,085	92,600	80,183
Last Close Price	1701.30	1417.35	838.59	568.87	677.58	590.51
PE Ratio	55.86	54.85	29.26	20.36	23.05	23.13
Forward PE	37.40	38.80	25.79	17.15	21.23	21.38
PS Ratio	7.76	6.70	5.76	4.68	7.06	6.89
PB Ratio	6.61	5.90	3.56	3.50	4.91	5.21
P/TBV Ratio	-	-	-	-	8.10	10.28
P/FCF Ratio	38.34	21.21	32.15	-	36.39	23.50
P/OCF Ratio	28.30	18.12	23.60	26.67	24.75	21.89
PEG Ratio	1.01	1.29	1.61	1.91	1.46	1.14
EV/Sales Ratio	8.67	7.71	6.09	4.82	6.98	6.72
EV/EBITDA Ratio	24.28	22.09	18.30	15.23	19.18	18.82
EV/EBIT Ratio	33.60	31.59	24.53	18.99	21.81	20.69
EV/FCF Ratio	42.85	24.39	33.98	-	36.00	22.94
Debt / Equity Ratio	0.68	0.76	0.86	0.40	0.05	0.01
Debt / EBITDA Ratio	2.24	2.44	4.13	1.66	0.19	0.04
Debt / FCF Ratio	3.95	2.72	7.79	-	0.36	0.05
Asset Turnover	0.42	0.41	0.37	0.56	0.65	0.70
Inventory Turnover	2.27	2.80	2.47	2.90	2.49	2.95
Quick Ratio	0.47	0.56	0.75	1.22	1.99	1.78
Current Ratio	0.91	0.89	0.91	1.73	3.14	2.80
Return on Equity (ROE)	13.42%	11.54%	14.59%	18.12%	23.29%	24.72%
Return on Assets (ROA)	6.78%	6.24%	5.77%	8.87%	12.92%	14.31%
Return on Capital (ROIC)	8.15%	7.47%	6.78%	10.31%	14.76%	16.70%
Return on Capital Employed (ROCE)	13.70%	12.40%	11.00%	13.10%	20.50%	23.20%
Earnings Yield	1.79%	1.82%	3.42%	4.91%	4.34%	4.32%
FCF Yield	2.61%	4.71%	3.11%	-7.07%	2.75%	4.26%
Dividend Yield	0.48%	0.52%	-	1.29%	0.89%	0.93%
Payout Ratio	24.10%	28.44%	-	26.14%	20.10%	21.03%
Buyback Yield / Dilution	-0.01%	-0.09%	-0.03%	-0.19%	-0.02%	1.03%
Total Shareholder Return	0.46%	0.43%	-0.03%	1.10%	0.86%	1.97%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.